Literature DB >> 19187774

Cideb, an ER- and lipid droplet-associated protein, mediates VLDL lipidation and maturation by interacting with apolipoprotein B.

Jing Ye1, John Zhong Li, Yang Liu, Xuanhe Li, Tianshu Yang, Xiaodong Ma, Qing Li, Zemin Yao, Peng Li.   

Abstract

Secretion of triacylglycerol-enriched very-low-density lipoproteins (VLDLs) from the liver is vital for maintaining plasma lipid homeostasis. However, the process of VLDL assembly and lipidation is not well characterized. Here, we observed that liver of Cideb null mice had higher levels of triacylglycerols accompanied by low level of VLDL secretion. Furthermore, VLDL particles secreted from hepatocytes of Cideb null mice have low levels of triacylglycerols but normal levels of apoB. We also observed that Cideb is localized to endoplasmic reticulum and lipid droplets. Importantly, we have identified apoB as a Cideb-interacting protein. By infecting adenoviruses expressing various Cideb truncations into hepatocytes of Cideb null mice, we found that Cideb requires both its apoB-binding and lipid droplet association domains to restore the secretion of triacylglycerol-enriched VLDL particles. Our data suggest that Cideb promotes the formation of triacylglycerol-enriched VLDL particles and provides a molecular insight into VLDL lipidation and maturation in hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19187774     DOI: 10.1016/j.cmet.2008.12.013

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  84 in total

Review 1.  The role of lipid droplets in metabolic disease in rodents and humans.

Authors:  Andrew S Greenberg; Rosalind A Coleman; Fredric B Kraemer; James L McManaman; Martin S Obin; Vishwajeet Puri; Qing-Wu Yan; Hideaki Miyoshi; Douglas G Mashek
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

2.  Opposing roles of cell death-inducing DFF45-like effector B and perilipin 2 in controlling hepatic VLDL lipidation.

Authors:  Xuanhe Li; Jing Ye; Linkang Zhou; Wei Gu; Edward A Fisher; Peng Li
Journal:  J Lipid Res       Date:  2012-06-01       Impact factor: 5.922

3.  Synergistic regulation of hepatic Fsp27b expression by HNF4α and CREBH.

Authors:  Carlos Ichiro Kasano-Camones; Masayuki Takizawa; Wakana Iwasaki; Shota Sasaki; Mume Hamada; Aoi Morimoto; Masakiyo Sakaguchi; Frank J Gonzalez; Yusuke Inoue
Journal:  Biochem Biophys Res Commun       Date:  2020-06-15       Impact factor: 3.575

Review 4.  Lipid transfer proteins in the assembly of apoB-containing lipoproteins.

Authors:  Alaa Sirwi; M Mahmood Hussain
Journal:  J Lipid Res       Date:  2018-04-12       Impact factor: 5.922

5.  Fsp27/CIDEC is a CREB target gene induced during early fasting in liver and regulated by FA oxidation rate.

Authors:  Anna Vilà-Brau; Ana Luísa De Sousa-Coelho; Joana F Gonçalves; Diego Haro; Pedro F Marrero
Journal:  J Lipid Res       Date:  2012-12-06       Impact factor: 5.922

6.  Fat-specific protein 27 undergoes ubiquitin-dependent degradation regulated by triacylglycerol synthesis and lipid droplet formation.

Authors:  Zongqian Nian; Zhiqi Sun; Luxin Yu; Shen Yon Toh; Jianli Sang; Peng Li
Journal:  J Biol Chem       Date:  2010-01-20       Impact factor: 5.157

Review 7.  Dynamics of hepatic and intestinal cholesterol and bile acid pathways: The impact of the animal model of estrogen deficiency and exercise training.

Authors:  Jean-Marc Lavoie
Journal:  World J Hepatol       Date:  2016-08-18

8.  Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion.

Authors:  Meenakshi Sundaram; Zemin Yao
Journal:  Nutr Metab (Lond)       Date:  2010-04-27       Impact factor: 4.169

Review 9.  Regulation of hepatic gene expression by saturated fatty acids.

Authors:  T Vallim; A M Salter
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2010-03-12       Impact factor: 4.006

10.  Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC.

Authors:  Oscar Rubio-Cabezas; Vishwajeet Puri; Incoronata Murano; Vladimir Saudek; Robert K Semple; Satya Dash; Caroline S S Hyden; William Bottomley; Corinne Vigouroux; Jocelyne Magré; Philippa Raymond-Barker; Peter R Murgatroyd; Anil Chawla; Jeremy N Skepper; V Krishna Chatterjee; Sara Suliman; Ann-Marie Patch; Anil K Agarwal; Abhimanyu Garg; Inês Barroso; Saverio Cinti; Michael P Czech; Jesús Argente; Stephen O'Rahilly; David B Savage
Journal:  EMBO Mol Med       Date:  2009-08       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.